Skip to main content

Table 1 Clinicopathological characteristics

From: Short-term outcomes of robotic- versus laparoscopic-assisted Total Gastrectomy for advanced gastric Cancer: a propensity score matching study

Variables

All Patients

Patients after PSM

RATG(n = 126)

LATG(n = 257)

p

RATG(n = 126)

LATG(n = 126)

p

Age, year (mean ± SD)

60.33 ± 8.94

58.26 ± 10.41

0.051

60.33 ± 8.94

60.78 ± 9.05

0.690

Sex (male/female)

105/21

197/60

0.133

105/21

100/26

0.419

Height, cm (mean ± SD)

163.52 ± 6.58

162.74 ± 7.25

0.304

163.52 ± 6.58

162.79 ± 7.91

0.422

Weight, Kg (mean ± SD)

59.21 ± 8.37

59.63 ± 9.46

0.667

59.21 ± 8.37

58.84 ± 9.70

0.745

BMI, Kg/m2(mean ± SD)

22.10 ± 2.48

22.46 ± 2.93

0.200

22.10 ± 2.48

22.13 ± 2.84

0.929

ASA (I/II/III)

87/36/3

185/68/4

0.529

87/36/3

94/30/2

0.320

Tumor size, cm (mean ± SD)

4.62 ± 2.22

4.55 ± 2.28

0.759

4.62 ± 2.22

4.40 ± 2.35

0.446

Tumor location

  

0.398

  

0.661

Siewert type II

28

61

 

28

28

 

Siewert type III

30

69

 

30

33

 

Body

68

127

 

68

65

 

Borrmann type

  

0.076

  

0.785

I/II/III/IV

3/11/100/12

11/27/207/12

 

3/11/100/12

2/10/106/8

 

Depth of infiltration (T)

  

0.023

  

0.796

T2

7

36

 

7

9

 

T3

2

3

 

2

1

 

T4a

117

218

 

117

116

 

Nodal status (N)

  

0.483

  

0.841

N0

29

64

 

29

30

 

N1

29

45

 

29

25

 

N2

27

43

 

27

25

 

N3a

21

61

 

21

29

 

N3b

20

44

 

20

17

 

TNM stage

  

0.814

  

0.803

IB

3

23

 

3

3

 

IIA

6

7

 

6

0

 

IIB

24

44

 

24

27

 

IIIA

52

81

 

52

45

 

IIIB

21

58

 

21

31

 

IIIC

20

44

 

20

10

 

Differentiation

  

0.006

  

0.534

G1/G2/G3

0/28/98

1/92/164

 

0/28/98

0/24/102

 

Comorbidities (0/1/2/3)

91/23/6/6

174/52/25/6

0.385

91/23/6/6

91/22/11/2

0.983

Abdominal surgery history (Y/N)

5/121

26/231

0.038

5/121

13/113

0.050

  1. RATG Robotic-assisted total gastrectomy, LATG Laparoscopic-assisted total gastrectomy, PSM Propensity Score Matching, SD Standard Deviation, BMI body mass index, ASA American Society of Anesthesiologists, TNM tumor-node-metastasis, G1/G2/G3 High/Middle/Low or Mucus differentiation, Comorbidities (0/1/2/3) no/one/two/three comorbidities, Y Yes, N No.